Kearbey, Jeffrey D.

Ibrutinib (Ibr) dose modification for management of early cardiac adverse events in patients with chronic lymphocytic leukemia: Pooled analysis of 7 clinical trials

Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 461-463

10.1002/hon.3164_340